Cargando…
Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107153/ https://www.ncbi.nlm.nih.gov/pubmed/33742364 http://dx.doi.org/10.1007/s12325-021-01642-9 |
_version_ | 1783689899899092992 |
---|---|
author | Pope, Janet Sawant, Ruta Tundia, Namita Du, Ella X. Qi, Cynthia Z. Song, Yan Tang, Patrick Betts, Keith A. |
author_facet | Pope, Janet Sawant, Ruta Tundia, Namita Du, Ella X. Qi, Cynthia Z. Song, Yan Tang, Patrick Betts, Keith A. |
author_sort | Pope, Janet |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8107153 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-81071532021-05-24 Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis Pope, Janet Sawant, Ruta Tundia, Namita Du, Ella X. Qi, Cynthia Z. Song, Yan Tang, Patrick Betts, Keith A. Adv Ther Letter Springer Healthcare 2021-03-20 2021 /pmc/articles/PMC8107153/ /pubmed/33742364 http://dx.doi.org/10.1007/s12325-021-01642-9 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/Open Access This article is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License, which permits any non-commercial use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Letter Pope, Janet Sawant, Ruta Tundia, Namita Du, Ella X. Qi, Cynthia Z. Song, Yan Tang, Patrick Betts, Keith A. Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis |
title | Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis |
title_full | Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis |
title_fullStr | Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis |
title_full_unstemmed | Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis |
title_short | Authors’ Response to Letter to the Editor Regarding Comparative Efficacy of JAK Inhibitors for Moderate-to-Severe Rheumatoid Arthritis: A Network Meta-Analysis |
title_sort | authors’ response to letter to the editor regarding comparative efficacy of jak inhibitors for moderate-to-severe rheumatoid arthritis: a network meta-analysis |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107153/ https://www.ncbi.nlm.nih.gov/pubmed/33742364 http://dx.doi.org/10.1007/s12325-021-01642-9 |
work_keys_str_mv | AT popejanet authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT sawantruta authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT tundianamita authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT duellax authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT qicynthiaz authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT songyan authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT tangpatrick authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis AT bettskeitha authorsresponsetolettertotheeditorregardingcomparativeefficacyofjakinhibitorsformoderatetosevererheumatoidarthritisanetworkmetaanalysis |